RXO's valuation has become more attractive following the fallout from the Lipe V. Lupus Superior verdict, in which a jury awarded approximat

RXO's valuation has become more attractive following the fallout from the Lipe V. Lupus Superior verdict, in which a jury awarded approximately $604M against Lupus Superior, its driver, and CHRW @ Benchmark